Discounted Cash Flow
Novo Nordisk A S ADR
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
| Dividends | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $17.4b | $7.4b | $-1.9b | 42.8% | $14.99 |
| 2017 | $17.4b (-0.1%) | $7.6b (1.8%) | $3.8b (300.1%) | 43.6% (1.9%) | $15.42 (2.9%) |
| 2018 | $17.4b (0.1%) | $7.4b (-2.2%) | $4.5b (19.4%) | 42.6% (-2.3%) | $15.96 (3.5%) |
| 2019 | $19.0b (9.1%) | $7.5b (2.0%) | $4.9b (8.3%) | 39.8% (-6.5%) | $16.41 (2.8%) |
| 2020 | $19.7b (4.0%) | $8.3b (9.4%) | $5.5b (11.6%) | 41.9% (5.2%) | $18.05 (10.0%) |
| 2021 | $21.9b (10.9%) | $9.2b (11.2%) | $5.5b (1.3%) | 42.0% (0.3%) | $20.79 (15.2%) |
| 2022 | $27.5b (25.7%) | $10.7b (16.9%) | $10.0b (80.4%) | 39.0% (-7.0%) | $24.51 (17.9%) |
| 2023 | $36.1b (31.3%) | $16.3b (51.6%) | $10.9b (9.2%) | 45.1% (15.5%) | $18.67 (-23.8%) |
| 2024 | $45.1b (25.0%) | $19.8b (21.5%) | $10.8b (-0.5%) | 43.8% (-2.8%) | $22.67 (21.4%) |
| 2025 | $48.0b (6.4%) | $20.3b (2.6%) | $4.5b (-58.4%) | 42.2% (-3.6%) | $23.06 (1.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
SEC filings report in DKK. Values above are converted to USD for comparison with the US-listed share price.
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Net debt deduction: —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.